KCM
EXAS

KRS Capital Management’s Exact Sciences EXAS Stock Holding History

KRS Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,090
Closed -$213K – 119
2024
Q1 		$213K Sell
3,090
-650
-17% -$41.1K 0.17% 114
2023
Q4 		$277K Buy
+3,740
New +$245K 0.26% 90
2022
Q1 		– Sell
-1,015
Closed -$78K – 199
2021
Q4 		$78K Buy
+1,015
New +$89.6K 0.07% 200

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

KRS Capital Management's EXAS Position: Q2 2024 in Review

KRS Capital Management sold out of Exact Sciences (EXAS) in Q2 2024, closing a stake of 3,090 shares — an estimated $213K sold.

KRS Capital Management first reported a position in EXAS in Q4 2021 and held it in 3 quarters. The position peaked at $277K in Q4 2023. 543 funds tracked by Wall St. Rank hold EXAS as of Q2 2024.

  • KRS Capital Management reported no remaining Exact Sciences position as of Q2 2024 after selling out during the quarter.
  • KRS Capital Management sold 3,090 Exact Sciences shares in Q2 2024, an estimated $213K.
  • KRS Capital Management first reported a position in Exact Sciences in Q4 2021 and held it in 3 quarters.
  • KRS Capital Management's Exact Sciences position peaked at $277K in Q4 2023.
  • 543 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2024.

Based on KRS Capital Management's 13F filing for Q2 2024, filed 17 Jul 2024.